NasdaqGM:IRONBiotechs
Disc Medicine’s (IRON) Rising Net Losses Could Be a Game Changer for Its Financial Strategy
Disc Medicine, Inc. reported that its net loss widened to US$55.25 million for the second quarter of 2025, up from US$26.35 million a year earlier, with a basic loss per share of US$1.58 compared to US$1.03 in the prior period.
These results mark a substantial increase in spending or reduced revenues over both the recent quarter and first half of the year.
We'll take a closer look at what rising net losses mean for Disc Medicine's investment outlook and future financial flexibility.
Uncover...